It is apparent that MALAT1 was significantly enriched with the EZH2 antibody and not with SUZ12 antibody and IgG (control antibody) in two MCL cell lines; P < 0.001; Fig. 3a–d). This evidence concerns the gene SUZ12 and mantle cell lymphoma.